| Literature DB >> 30790268 |
Hannah C Glass1,2, Janet S Soul3, Catherine J Chu4, Shavonne L Massey5, Courtney J Wusthoff6, Taeun Chang7, Maria Roberta Cilio1, Sonia L Bonifacio8, Nicholas S Abend5,9, Cameron Thomas10, Monica Lemmon11, Charles E McCulloch2, Renée A Shellhaas12.
Abstract
In a prospective cohort of 534 neonates with acute symptomatic seizures, 66% had incomplete response to the initial loading dose of antiseizure medication (ASM). Treatment response did not differ by gestational age, sex, medication, or dose. The risk of incomplete response was highest for seizures due to intracranial hemorrhage and lowest for hypoxic-ischemic encephalopathy, although the difference was not significant after adjusting for high seizure burden and therapeutic hypothermia treatment. Future trial design may test ASMs in neonates with all acute symptomatic seizure etiologies and could target neonates with seizures refractory to an initial ASM. Wiley Periodicals, Inc.Entities:
Keywords: zzm321990AEDzzm321990; antiepileptic drug; electroencephalogram; epilepsy; hypoxic-ischemic encephalopathy; neonatal encephalopathy; neonatal seizures; neurocritical care; seizure
Mesh:
Substances:
Year: 2019 PMID: 30790268 PMCID: PMC6443409 DOI: 10.1111/epi.14671
Source DB: PubMed Journal: Epilepsia ISSN: 0013-9580 Impact factor: 5.864